Cargando…
Melanoma Cell State-Specific Responses to TNFα
Immune checkpoint inhibitors that target the programmed cell death protein 1 (PD1) pathway have revolutionized the treatment of patients with advanced metastatic melanoma. PD1 inhibitors reinvigorate exhausted tumor-reactive T cells, thus restoring anti-tumor immunity. Tumor necrosis factor alpha (T...
Autores principales: | Lim, Su Yin, Alavi, Sara, Ming, Zizhen, Shklovskaya, Elena, Fung, Carina, Stewart, Ashleigh, Rizos, Helen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230114/ https://www.ncbi.nlm.nih.gov/pubmed/34073253 http://dx.doi.org/10.3390/biomedicines9060605 |
Ejemplares similares
-
Interferon Signaling Is Frequently Downregulated in Melanoma
por: Alavi, Sara, et al.
Publicado: (2018) -
Durable Responses to Anti-PD1 and Anti-CTLA4 in a Preclinical Model of Melanoma Displaying Key Immunotherapy Response Biomarkers
por: Shklovskaya, Elena, et al.
Publicado: (2022) -
The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma
por: Lim, Su Yin, et al.
Publicado: (2023) -
Genetic Alterations in the INK4a/ARF Locus: Effects on Melanoma Development and Progression
por: Ming, Zizhen, et al.
Publicado: (2020) -
Spatial and Temporal Changes in PD-L1 Expression in Cancer: The Role of Genetic Drivers, Tumor Microenvironment and Resistance to Therapy
por: Shklovskaya, Elena, et al.
Publicado: (2020)